What and how should regular cancer prevention check-ups be conducted?

The Health China Action (2019-2030), issued recently in China, aims to basically realize that high-risk groups of cancer participate in regular cancer prevention physical examination. What and how to check for cancer prevention physical examination?
Healthy China Action mentioned that standardized cancer prevention physical examination is an important way to detect cancer and precancerous lesions. Zhang Kai, deputy director of the cancer prevention department of the National Cancer Center and the Cancer Hospital of the Chinese Academy of Medical Sciences, said that unlike the state-paid organizational screening, the cost of cancer prevention physical examination is mainly borne by the examiners themselves, and should be more targeted. According to Zhang Kai, regular screening should be carried out for major cancers. "The main cancers in China include lung cancer, breast cancer, colorectal cancer, gastric cancer, liver cancer, esophageal cancer, cervical cancer, prostate cancer and so on. The first six cancers account for about 70% of all cancers and nearly 80% of deaths. Lung cancer has the highest incidence in males and breast cancer in females.
Healthy China Action mentions that most common cancers can be detected early by current technical means. It is suggested that high-risk groups choose professional medical institutions for regular cancer prevention physical examination and choose appropriate intervals according to individual age and previous examination results. According to the high-risk population mentioned in the document, Zhang Kai said that the first high-risk factor for cancer incidence was age. The population over 50 years old is the key target of most malignant tumors. Cancer screening should be paid attention to after 40 years old. Routine anti-cancer physical examination can be carried out over 50 years old. "However, breast cancer and cervical cancer should be examined at the age of 45 and 21 respectively."
He said that determining whether he is a high-risk group depends not only on his age, but also on what kind of cancer he is at high risk. For example, long-term smokers are at high risk of lung cancer, and hepatitis virus carriers are at high risk of liver cancer, so screening should be carried out according to their own characteristics.
Zhang Kai suggested that the best way to improve the early diagnosis rate is to identify effective means, take into account safety and minimally invasive, on the premise of screening and appropriate technology. For the interval of physical examination, the development time of each disease is different. For example, hepatocellular carcinoma progresses rapidly, and the high-risk population usually has to be examined once in six to eight months. If there is no problem with colonoscopy, a second examination can be performed at intervals of 5 to 10 years.
"Cancer prevention physical examination should be targeted and individualized, and screening items should be selected according to age, family history, gender, living habits and other factors, combined with their own conditions." Zhang Kai prompted.
Looking for chemical products? Let suppliers reach out to you!
2026-07-17
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Nuohui Health tore off the 'B label', the beginning of China's cancer early screening industry to regain confidence
-
Consino Bio inhalation COVID-19 vaccine arrives in Morocco
-
The female Jobs $9 billion scam failed, is the 'drop blood cancer test' a shocking scam, or a ray of hope?
-
L’ORÉAL SUED OVER HAIR STRAIGHTENING-PRODUCTS CANCER CLAIMS
-
Will the mRNA cancer vaccine come true?
-
Genentech Team Discovers New Cancer Immunotherapy Target - ESCRT
-
China Small Molecule Innovative Drugs Industry Trends to 2022
-
Prevent Diseases: Osimertinib Mechanism of Action
-
China sees rising exports of epidemic prevention supplies
-
The European Union completely banned ranitidine or carcinogens
Recommend Reading
-
The Pill That Could Swallow the Needle: Novo Nordisk Launches Oral Wegovy in U.S. Weight-Loss Revolution
-
The $6 Billion Gold Rush: Generic Semaglutide Set to Reshape Global Pharma After Patent Cliff
-
MENA Pharmaceutical Regulatory Updates 2026: Key Compliance Changes for Global Pharma Companies
-
FDA Fee Updates Raise the Cost of Entering the U.S. Generic Drug Chain
-
API Supplier Audits Move to the Center of Pharma Supply Resilience
-
Supply Maintains Contraction, Boosting PTA Prices in China
-
Covestro Unveils TPU Application Development Hub in Guangzhou, Strengthening Regional Innovation Network
-
Premium Global Chemical Sourcing Requests (19 - 22 Mar, 2026)
-
Caffeine Structure & Effects: What You Should Know
-
In August, the Chinese soda ash market continued to decline